{"title":"Relationship of TMAO levels with vascular function in patients with hypertension.","authors":"Takayuki Yamaji, Yuji Takaeko, Farina Mohamad Yusoff, Shinji Kishimoto, Masato Kajikawa, Yukiko Nakano, Takanori Harada, Takahiro Harada, Aya Mizobuchi, Yusuke Saito, Shunsuke Tanigawa, Tatsuya Maruhashi, Ayumu Nakashima, Yukihito Higashi","doi":"10.1038/s41440-025-02346-1","DOIUrl":null,"url":null,"abstract":"<p><p>Increased trimethylamine-N-oxide (TMAO) level is a known risk factor for hypertension. Hypertension is associated with vascular dysfunction. Recently, it has been shown that endothelial function is impaired in relation to an increase in TMAO level. However, there is no information on the relationship between TMAO levels and vascular function in patients with hypertension. The purpose of this study was to evaluate the independent variables for circulating TMAO levels and to evaluate the relationships of circulating TMAO levels with vascular function assessed by flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID) in patients with hypertension. This study was a cross-sectional study. A total of 333 subjects with hypertension were enrolled in this study. Log TMAO levels were significantly correlated with age (r = 0.24, p < 0.01), low-density lipoprotein cholesterol (r = -0.15, p < 0.01), creatinine (r = 0.28, p < 0.01), estimated glomerular filtration rate (eGFR) (r = -0.28, p < 0.01), and uric acid (r = 0.13, p = 0.02). Multiple linear regression analysis revealed that age (β = 0.17, p = 0.03), eGFR (β = -0.22, p < 0.01) and receiving three or more kinds of antihypertensive drugs (β = 0.15, p = 0.02) were independent predictors of log TMAO levels. FMD (r = -0.11, p = 0.04) and NID (r = -0.11, p = 0.04) were significantly correlated with log TMAO levels. After adjustment for confounding factors for vascular function, log TMAO level was not an independent predictor of FMD and NID. These findings suggest that circulating TMAO levels are associated with age, eGFR, and receiving three or more kinds of antihypertensive drugs but not with vascular function in patients with hypertension. Clinical Trial Registry Information: http://www.umin.ac.jp (UMIN000003409).</p>","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":" ","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hypertension Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41440-025-02346-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Increased trimethylamine-N-oxide (TMAO) level is a known risk factor for hypertension. Hypertension is associated with vascular dysfunction. Recently, it has been shown that endothelial function is impaired in relation to an increase in TMAO level. However, there is no information on the relationship between TMAO levels and vascular function in patients with hypertension. The purpose of this study was to evaluate the independent variables for circulating TMAO levels and to evaluate the relationships of circulating TMAO levels with vascular function assessed by flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID) in patients with hypertension. This study was a cross-sectional study. A total of 333 subjects with hypertension were enrolled in this study. Log TMAO levels were significantly correlated with age (r = 0.24, p < 0.01), low-density lipoprotein cholesterol (r = -0.15, p < 0.01), creatinine (r = 0.28, p < 0.01), estimated glomerular filtration rate (eGFR) (r = -0.28, p < 0.01), and uric acid (r = 0.13, p = 0.02). Multiple linear regression analysis revealed that age (β = 0.17, p = 0.03), eGFR (β = -0.22, p < 0.01) and receiving three or more kinds of antihypertensive drugs (β = 0.15, p = 0.02) were independent predictors of log TMAO levels. FMD (r = -0.11, p = 0.04) and NID (r = -0.11, p = 0.04) were significantly correlated with log TMAO levels. After adjustment for confounding factors for vascular function, log TMAO level was not an independent predictor of FMD and NID. These findings suggest that circulating TMAO levels are associated with age, eGFR, and receiving three or more kinds of antihypertensive drugs but not with vascular function in patients with hypertension. Clinical Trial Registry Information: http://www.umin.ac.jp (UMIN000003409).
三甲胺- n -氧化物(TMAO)水平升高是高血压的已知危险因素。高血压与血管功能障碍有关。最近,研究表明,内皮功能受损与TMAO水平的增加有关。然而,没有关于TMAO水平与高血压患者血管功能之间关系的信息。本研究的目的是评估循环TMAO水平的独立变量,并评估循环TMAO水平与高血压患者血流介导的血管舒张(FMD)和硝酸甘油诱导的血管舒张(NID)评估的血管功能的关系。这项研究是一项横断面研究。本研究共纳入333例高血压患者。Log TMAO水平与年龄显著相关(r = 0.24, p
期刊介绍:
Hypertension Research is the official publication of the Japanese Society of Hypertension. The journal publishes papers reporting original clinical and experimental research that contribute to the advancement of knowledge in the field of hypertension and related cardiovascular diseases. The journal publishes Review Articles, Articles, Correspondence and Comments.